Inventor · disambiguated record
Andrew Kruse
Also filed as: KRUSE ANDREW · KRUSE ANDREW CURTIS
13 granted patents·7 pending applications·141 citations·filing 2014–2024
90Inventor score
Files withUNIV LELAND STANFORD JUNIOR9AB INITIO BIOTHERAPEUTICS INC3VIB VZW3UNIV CALIFORNIA2HARVARD COLLEGE1
Top patents by PatentIndex Score
20 records- 0197US9562087B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Feb 7, 2017·45 cites·30 claims
- 0297US9546206B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Jan 17, 2017·33 cites·27 claims
- 0396US9845345B2SIRP polypeptide compositions and methods of useAB INITIO BIOTHERAPEUTICS INC·Filed 2016·Granted Dec 19, 2017·44 cites·23 claims
- 0494US10774125B2SIRP-gamma polypeptide compositions and methods of useAB INITIO BIOTHERAPEUTICS INC·Filed 2017·Granted Sep 15, 2020·10 cites·17 claims
- 0593US10800830B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Oct 13, 2020·6 cites·17 claims
- 0690US11407801B2SIRP-gamma polypeptide compositions and treatment of cancerAB INITIO BIOTHERAPEUTICS INC·Filed 2020·Granted Aug 9, 2022·2 cites·6 claims
- 0784US2024174729A1High affinity pd-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2023·Application pending·0 cites
- 0873US10829771B2Compositions and methods for expressing polypeptides on the surface of cellsUNIV LELAND STANFORD JUNIOR·Filed 2015·Granted Nov 10, 2020·1 cites·28 claims
- 0972US11814419B2High affinity PD-1 agents and methods of useUNIV LELAND STANFORD JUNIOR·Filed 2020·Granted Nov 14, 2023·0 cites·25 claims
- 1072US11041868B2Compositions comprising G protein-coupled receptors maintained in a conformationally selective manner by a modulatorUNIV LELAND STANFORD JUNIOR·Filed 2019·Granted Jun 22, 2021·0 cites·22 claims
- 1169US2021340249A1Muscarinic acetylcholine receptor binding agents and uses thereofVIB VZW·Filed 2021·Application pending·0 cites
- 1267US10520516B2Complexes comprising transmembrane receptors and antibodies that bind the receptors in a conformationally selective mannerUNIV LELAND STANFORD JUNIOR·Filed 2017·Granted Dec 31, 2019·0 cites·21 claims
- 1366US2024182911A1Protein Engineering via Error-Prone Orthogonal Replication and Yeast Surface DisplayUNIV CALIFORNIA·Filed 2024·Application pending·0 cites
- 1465US9880179B2Method for selecting agents that bind to transmembrane receptors in a conformationally selective mannerUNIV LELAND STANFORD JUNIOR·Filed 2014·Granted Jan 30, 2018·0 cites·30 claims
- 1562US11946055B2Protein engineering via error-prone orthogonal replication and yeast surface displayUNIV CALIFORNIA·Filed 2021·Granted Apr 2, 2024·0 cites·12 claims
- 1661US2015368339A1Muscarinic acetylcholine receptor binding agents and uses thereofVIB VZW·Filed 2014·Application pending·0 cites
- 1760US2018222978A1Muscarinic acetylcholine receptor binding agents and uses thereofVIB VZW·Filed 2018·Application pending·0 cites
- 1858US12509497B2Relaxin-2 fusion protein analogs and methods of using sameTECTONIC OPERATING COMPANY INC·Filed 2022·Granted Dec 30, 2025·0 cites·12 claims
- 1955US2023174610A1Engineered relaxins and methods of use thereofHARVARD COLLEGE·Filed 2021·Application pending·0 cites
- 2037US2020000822A1Methods of treatment for cancer, sterol homeostasis, and neurological diseasesUNIV TEXAS·Filed 2018·Application pending·0 cites
Join the waitlist — get patent alerts
Get an alert when Andrew Kruse files or is granted a new patent.
We store only your email — no account needed. See our privacy policy.
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →